CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shinpoong Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shinpoong Pharmaceutical Co Ltd
7, Wonsi-ro, Danwon-gu
Phone: +82 314916191p:+82 314916191 ANSAN, 15610  South Korea Ticker: 019170019170
Business Summary
Shin Pooong Pharm., Co. Ltd is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. The Company's product portfolio consists of antibiotics, cardiovascular drugs, anti-cancer drugs, psychoneurotic drugs, antirheumatic drugs, antidiabetics, antifungal agents, antihistamines, antiviral agents, benign prostatic hyperplasia (BPH) drugs and trichogens. The Company also provides active pharmaceutical ingredients (APIs) synthesized by the Company, including non-steroidal anti-inflammatory drugs (NSAIDs), cardiovascular drugs, anti-ulcer drugs, respiratory drugs, antispasmodics drugs and others. The Company distributes its products within domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Je ManYoo 67 3/21/2014 3/21/2014
Managing Director Ju YeongSung 57 12/1/2023 3/31/2023
Managing Director CheongJoo 50 1/1/2016 1/1/2016
10 additional Officers and Directors records available in full report.

Business Names
Business Name
019170
019175
Korea SP Pharm Inc.
Shinpoong Pharm. Co., Ltd. (Parent)
Shinpoong Pharmaceutical Co., Ltd
Shinpoong Pharmaceutical Co., Ltd.

General Information
Number of Employees: 840 (As of 12/31/2015)
Outstanding Shares: 49,271,029 (As of 12/31/2023)
Shareholders: 146,231
Stock Exchange: KRX
Fax Number: +82 221893439


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024